C2 PHARMA is a growing APl supplier with a portfolio of complex chemical compounds obtained from natural and synthetic origins.
The current API product portfolio includes cyclopentolate, tropicamide, atropine, digoxin, homatropine, pilocarpine, brimonidine, latanoprost, bimatoprost and reaches more than 200 pharmaceutical companies across the United States, Western and Eastern Europe, South America, Asia, Middle-East and Africa.
Sustainability, supply chain security and quality are cornerstones of the C2 PHARMA approach, with extensive work being done daily to ensure that products reach customers at the right quality, on time. As a key sponsor of the “Partnerships for a Better World” program, C2 PHARMA reflects the company commitment to ethical business practices by investing in sustainable, traceable and fair-trade harvesting and sourcing of raw materials for the manufacturing of phytochemical APIs like pilocarpine. The program sustains more than 1,000 families and contributes to the preservation of Brazilian biodiversity.
C2 PHARMA is able to offer a unique level of support to pharma companies with the ability to acquire (or manage) APIs and drug products that are non-core, below critical mass, difficult to manufacture or challenging to distribute. The C2 PHARMA portfolio is further complemented by services from independently-owned affiliate companies Logistics4Pharma and ASM Research Chemicals. Logistics4Pharma offers customized cold-chain logistics and warehousing solutions, while ASM Research Chemicals supports research and development (R&D)-scale contract synthesis services, analytical services, phytochemical profiling and impurities manufacturing.
COMMITTED TO QUALITY
C2 PHARMA is a specialized API manufacturer and distributor that is committed to ethical business practices, sustainability, quality and reliability.
API LIFECYCLE MANAGEMENT
C2 PHARMA offers a dependable portfolio of exceptional APIs for the life of pharmaceutical processes. Additional support can be offered to pharma companies that are looking for a manufacturer to acquire or manage APIs and drug products that are non-core, below critical mass, difficult to manufacture or challenging to distribute.
COLD-CHAIN STORAGE & LOGISTICS
C2 PHARMA can support customers with preferred access to enhanced cold chain and fully-GDP compliant transport and storage solutions through affiliate, Logistics4Pharma.
R&D-SCALE CONTRACT SYNTHESIS SERVICES
C2 PHARMA has preferred access to R&D-scale (non-GMP) contract synthesis services, analytical services, phytochemical profiling and impurities manufacturing through its affiliate, ASM Research Chemicals.
AEO Status: https://logistics4pharma.com/aeo-status/
Phyto and Synthetic APIs, cyclopentolate, tropicamide, atropine, digoxin, homatropine, pilocarpine, brimonidine, latanoprost, bimatoprost